Jodi Fiske v. HHS - Influenza, small fiber neuropathy (2024)

On September 28, 2017, Jodi Fiske filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she developed small fiber neuropathy (SFN) as a result of an influenza vaccine received on September 29, 2014. Petitioner testified that approximately five days after vaccination, she began experiencing tingling and numbness in her feet, which spread to her legs, arms, and hands over the following days, accompanied by fatigue and a sensation of weakness.

Her symptoms continued to worsen in October 2014, impacting her ability to perform tasks at work and at home. Over the subsequent years, various treating physicians noted symptoms consistent with neuropathy, with some suspecting a link to the flu vaccine.

On August 21, 2017, a skin biopsy was performed, which was later interpreted as consistent with small fiber neuropathy. On January 24, 2018, a treating neurologist assessed Petitioner with SFN, noting the abnormal skin biopsy.

The respondent initially contested entitlement, arguing that the evidence did not support an SFN diagnosis or that the vaccine caused it. Following an entitlement hearing, Special Master Katherine E.

Oler issued a ruling on November 13, 2023, finding that Petitioner had preponderantly demonstrated that the flu vaccine caused her SFN and was therefore entitled to compensation. A subsequent decision on May 21, 2024, awarded Petitioner $98,589.87.

This award comprised $92,500.00 for pain and suffering and $6,089.87 for past unreimbursed expenses, to be paid as a lump sum. Petitioner was represented by Andrew Downing of Downing, Allison & Jorgenson, and Respondent was represented by Katherine Edwards of the U.S.

Department of Justice.